Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 3/2007

01.03.2007 | Rhinology

Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of Cε mRNA expression in human tonsil-derived cells

verfasst von: Shigeto Ohta, Kazuhiko Hanashiro, Masanori Sunagawa, Tetsuya Tono, Mikio Suzuki, Tadayoshi Kosugi

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

The aim of our study was to investigate a possible correlation between Epstein-Barr virus (EBV) infection status, including its latent gene expression, and expression of allergy-related genes in human tonsil-derived cells. In the tonsil-derived cells from the patients undergoing routine tonsillectomies for palatine tonsil hypertrophy or tonsillar focal infection, the presence of EBV DNA and mRNA expressions of latent membrane protein (LMP)-1, Cε chain, and activation-induced cytidine deaminase (AID) were detected by PCR and RT-PCR analysis, respectively. Of all the 12 patients, PCR products amplified from EBV DNA BamHI W fragment were detected in the tonsils from the 10 patients (83.3%). LMP1 mRNA expressions were confirmed in the six patients (50%). Both LMP1 mRNA expressions and EBV DNA were detected in the five patients. EBV DNA, but not LMP1 mRNA expression, was detected in the five patients. LMP1 mRNA expression, but not EBV DNA, was detected in one patient. In one patient, neither EBV DNA nor LMP1 mRNA expression was confirmed. Cε mRNA expressions were confirmed in all the 12 patients along with AID mRNA expressions. The degree of Cε mRNA expression, however, varied with the patients. The Fisher’s exact probability test revealed a statistically significant correlation between LMP1 and Cε gene expressions, indicating that Cε mRNA expression level was significantly higher in the LMP1 positive samples than in the negative samples. On the other hand, there was no significant correlation between AID and LMP1 mRNA expressions. Thus, EBV infection is a notable factor capable of exacerbating allergic inflammation.
Literatur
1.
Zurück zum Zitat Babcock GJ, Thorley-Lawson DA (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci USA 97:12250–12255PubMedCrossRef Babcock GJ, Thorley-Lawson DA (2000) Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors. Proc Natl Acad Sci USA 97:12250–12255PubMedCrossRef
2.
Zurück zum Zitat Bahna SL, Horwitz CA, Fiala M, Heiner DC (1978) IgE response in heterophil-positive infectious mononucleosis. J Allergy Clin Immunol 62:167–173PubMedCrossRef Bahna SL, Horwitz CA, Fiala M, Heiner DC (1978) IgE response in heterophil-positive infectious mononucleosis. J Allergy Clin Immunol 62:167–173PubMedCrossRef
3.
Zurück zum Zitat Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG (1999) The Epstein-Barr virus and its association with human cancers. Mol Pathol 52:307–322PubMedCrossRef Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG (1999) The Epstein-Barr virus and its association with human cancers. Mol Pathol 52:307–322PubMedCrossRef
4.
Zurück zum Zitat Brown KD, Hostager BS, Bishop GA (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193:943–954PubMedCrossRef Brown KD, Hostager BS, Bishop GA (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193:943–954PubMedCrossRef
5.
6.
Zurück zum Zitat Calvani M, Alessandri C, Paolone G, Rosengard L, Di Caro A, De Franco D (1997) Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease. Pediatr Allergy Immunol 8:91–96PubMed Calvani M, Alessandri C, Paolone G, Rosengard L, Di Caro A, De Franco D (1997) Correlation between Epstein Barr virus antibodies, serum IgE and atopic disease. Pediatr Allergy Immunol 8:91–96PubMed
8.
Zurück zum Zitat Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. Embo J 16:6131–6140PubMedCrossRef Gires O, Zimber-Strobl U, Gonnella R, Ueffing M, Marschall G, Zeidler R, Pich D, Hammerschmidt W (1997) Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. Embo J 16:6131–6140PubMedCrossRef
9.
Zurück zum Zitat King CL, Thyphronitis G, Nutman TB (1990) Enumeration of IgE secreting B cells. A filter spot-ELISA. J Immunol Methods 132:37–43PubMedCrossRef King CL, Thyphronitis G, Nutman TB (1990) Enumeration of IgE secreting B cells. A filter spot-ELISA. J Immunol Methods 132:37–43PubMedCrossRef
10.
Zurück zum Zitat Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ (1997) Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100:1969–1979PubMedCrossRef Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ (1997) Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100:1969–1979PubMedCrossRef
11.
Zurück zum Zitat Li HP, Chang YS (2003) Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 10:490–504PubMedCrossRef Li HP, Chang YS (2003) Epstein-Barr virus latent membrane protein 1: structure and functions. J Biomed Sci 10:490–504PubMedCrossRef
12.
Zurück zum Zitat Oettgen HC, Geha RS (2001) IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 107:429–440PubMedCrossRef Oettgen HC, Geha RS (2001) IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 107:429–440PubMedCrossRef
13.
Zurück zum Zitat Okudaira H, Mori A (1999) Concepts of the pathogenesis of allergic disease: possible roles of Epstein-Barr virus infection and interleukin-2 production. Int Arch Allergy Immunol 120:177–184PubMedCrossRef Okudaira H, Mori A (1999) Concepts of the pathogenesis of allergic disease: possible roles of Epstein-Barr virus infection and interleukin-2 production. Int Arch Allergy Immunol 120:177–184PubMedCrossRef
14.
Zurück zum Zitat Rystedt I, Strannegard IL, Strannegard O (1984) Increased serum levels of antibodies to Epstein-Barr virus in adults with history of atopic dermatitis. Int Arch Allergy Appl Immunol 75:179–183PubMed Rystedt I, Strannegard IL, Strannegard O (1984) Increased serum levels of antibodies to Epstein-Barr virus in adults with history of atopic dermatitis. Int Arch Allergy Appl Immunol 75:179–183PubMed
15.
Zurück zum Zitat Strannegard IL, Strannegard O (1981) Epstein-Barr virus antibodies in children with atopic disease. Int Arch Allergy Appl Immunol 64:314–319PubMed Strannegard IL, Strannegard O (1981) Epstein-Barr virus antibodies in children with atopic disease. Int Arch Allergy Appl Immunol 64:314–319PubMed
16.
Zurück zum Zitat Thyphronitis G, Tsokos GC, June CH, Levine AD, Finkelman FD (1989) IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma. Proc Natl Acad Sci USA 86:5580–5584PubMedCrossRef Thyphronitis G, Tsokos GC, June CH, Levine AD, Finkelman FD (1989) IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma. Proc Natl Acad Sci USA 86:5580–5584PubMedCrossRef
17.
Zurück zum Zitat Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H (1999) Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300–303PubMedCrossRef Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H (1999) Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses. Science 286:300–303PubMedCrossRef
18.
Zurück zum Zitat Uhara H, Sato Y, Mukai K, Akao I, Matsuno Y, Furuya S, Hoshikawa T, Shimosato Y, Saida T (1990) Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 81:272–278PubMed Uhara H, Sato Y, Mukai K, Akao I, Matsuno Y, Furuya S, Hoshikawa T, Shimosato Y, Saida T (1990) Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization. Jpn J Cancer Res 81:272–278PubMed
19.
Zurück zum Zitat Yamanaka N, Kataura A (1984) Viral infections associated with recurrent tonsillitis. Acta Otolaryngol Suppl 416:30–37PubMed Yamanaka N, Kataura A (1984) Viral infections associated with recurrent tonsillitis. Acta Otolaryngol Suppl 416:30–37PubMed
20.
Zurück zum Zitat Yanagihara Y (2003) Regulatory mechanism of human IgE synthesis. Allergol Int 52:1–12CrossRef Yanagihara Y (2003) Regulatory mechanism of human IgE synthesis. Allergol Int 52:1–12CrossRef
21.
Zurück zum Zitat Young LS, Dawson CW, Eliopoulos AG (2000) The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol 53:238–247PubMedCrossRef Young LS, Dawson CW, Eliopoulos AG (2000) The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol 53:238–247PubMedCrossRef
Metadaten
Titel
Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of Cε mRNA expression in human tonsil-derived cells
verfasst von
Shigeto Ohta
Kazuhiko Hanashiro
Masanori Sunagawa
Tetsuya Tono
Mikio Suzuki
Tadayoshi Kosugi
Publikationsdatum
01.03.2007
Verlag
Springer-Verlag
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 3/2007
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-006-0191-y

Weitere Artikel der Ausgabe 3/2007

European Archives of Oto-Rhino-Laryngology 3/2007 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.